<DOC>
	<DOCNO>NCT02231255</DOCNO>
	<brief_summary>Documentation effect direct overlap switch another dopamine agonist Sifrol® motor function , psychopathological disturbance mood , assessment reason switch reason use Sifrol® , equivalent dos end switch tolerability Sifrol® ambulatory patient suffer idiopathic Parkinson 's disease routine condition</brief_summary>
	<brief_title>Post Marketing Surveillance Study Patients With Idiopathic Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Patients Idiopathic Parkinson 's disease plan undergo switch another dopamine agonist Sifrol® Neurologists psychiatrists ask consider Summary Product Characteristics ( SPC ) Sifrol®</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>